ImmunoTargets and Therapy

Aims and Scope

Editor-in-Chief: Professor Michael R Shurin

ImmunoTargets and Therapy is an international journal that aims to present and publish basic and clinical research on the aspects of immunology in health and disease. ImmunoTargets and Therapy is primarily focused on the immunological basis of disease and explores the evidence behind new and existing immunotherapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.

Specific Topics covered in this journal include: 

• Biology and pathophysiology of the immune system in health and disease
• Immunological basis and immunological markers of diseases
• Potential targets for immune based therapy including therapeutic and prophylactic vaccines
• Novel and improved targets for immunodiagnostics and immunomonitoring
• Treatment protocols to improve management of patient with immune-mediated diseases
• Impact of management programs and new therapeutic agents
• Protocols on patient perspectives such as quality of life, adherence, and satisfaction

Studies based on in-vitro research need to be supported by comprehensive experimental validation of results.

ImmunoTargets and Therapy will no longer consider meta-analyses for publication.